Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer

Figure 4

Pretreatment Allred scores ratios of ER-α/ER-β and post-treatment Ki67 expression. Immunohistochemical staining showing different examples of ER-α/ER-β ratios: Case 2 (ratio < 1) with a poor variation in Ki67 level; Case 37 (ratio between 1 and 1.5) with a significant difference in Ki67 level after treatment and Case 28 (ratio > 1.5) with no significant change in Ki67 expression.

Back to article page